Roy D. Baynes - Director at Nurix Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
NRIX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Roy D. Baynes since 25 May 2025

Holdings reported by Roy D. Baynes for Nurix Therapeutics, Inc.

Form 4 holding Director

Nurix Therapeutics, Inc.

Security class
Director Stock Option (right to buy)
Shares / value
31,250
Estimated value
Report date
15 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transactions reported by Roy D. Baynes for Nurix Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .